1naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
1nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
Table 1: Included patient characteristics (N = 40)
Patient Characteristics Value (SD) Mean age (yr) 61.5 (11.1) Age range (yr) 29–81 Male/female ratio 23:17 Pathology Primary CNS large B-cell lymphoma 40 Prior WBRT 5 Median follow-up (yr)a 3.01 Total baseline MR imaging 33 Total baseline CT 7 Total follow-up MR imaging 254 Total follow-up CT 10 Mean number of MR images per patient 7.60 (3.49) Mean number of lesions on baseline MR image 2.33 (1.14) Disease location Superficial 16 Deep 15 Mixed 9 Particular disease distribution Midline crossing lesion 10 Multifocal, bilateral lesions 16 Induction responsea 22 Relapse after inductiona 12
Note:—WBRT indicates whole brain radiotherapy; SD, standard deviation.
↵a One patient was lost to follow-up, and 5 stopped their treatment for palliative care and were not included in this analysis.